Skip to main content
SpringerLink
Log in

mRNA Vaccination and Personalized Cancer Therapy

  • Chapter
  • First Online:
Cancer Immunotherapy Meets Oncology

Abstract

Nucleic acid vaccines link two prerequisites for success, namely, the delivery of molecularly defined antigens as vaccine targets of interest and an inherent adjuvant activity. As compared to DNA-based approaches, in vitro-transcribed messenger RNA (mRNA) is a safer drug format due to the adjustable, transient expression and lack of genomic integration. In contrast to viral vector vaccines, mRNA vaccination is not limited by the emergence of immune responses against antigens produced by the viral vector backbones. Thus, mRNA vaccines are particularly attractive for cancer immunotherapy for which induction of clinically meaningful antigen-specific immune responses depends on repeated immunization cycles. With favorable platform features such as rapid production, easy upscaling, and low production costs, mRNA immunotherapies are rapidly evolving as a novel drug format in oncology. mRNA is currently utilized in the clinic by either transfecting antigen-presenting cells in vitro which are transferred back to the patient afterwards or by direct in vivo application to the patient. This chapter provides a short summary of the history of mRNA-based vaccination and introduces into the design and production of mRNA vaccines. The principles of various strategies for mRNA delivery with a focus on direct in vivo vaccination are discussed. Finally, the review provides insights into the preclinical development and clinical translation of personalized mRNA vaccines which are tailored to the antigen profile of individual cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV, Bignell GR, Bolli N, Borg A, Borresen-Dale AL, Boyault S, Burkhardt B, Butler AP, Caldas C, Davies HR, Desmedt C, Eils R, Eyfjord JE, Foekens JA, Greaves M, Hosoda F, Hutter B, Ilicic T, Imbeaud S, Imielinski M, Jager N, Jones DT, Jones D, Knappskog S, Kool M, Lakhani SR, Lopez-Otin C, Martin S, Munshi NC, Nakamura H, Northcott PA, Pajic M, Papaemmanuil E, Paradiso A, Pearson JV, Puente XS, Raine K, Ramakrishna M, Richardson AL, Richter J, Rosenstiel P, Schlesner M, Schumacher TN, Span PN, Teague JW, Totoki Y, Tutt AN, Valdes-Mas R, van Buuren MM, van’t Veer L, Vincent-Salomon A, Waddell N, Yates LR, Zucman-Rossi J, Futreal PA, McDermott U, Lichter P, Meyerson M, Grimmond SM, Siebert R, Campo E, Shibata T, Pfister SM, Campbell PJ, Stratton MR (2013) Signatures of mutational processes in human cancer. Nature 500:415–421

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Baer BW, Kornberg RD (1980) Repeating structure of cytoplasmic poly(A)-ribonucleoprotein. Proc Natl Acad Sci U S A 77:1890–1892

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Balagopal V, Fluch L, Nissan T (2012) Ways and means of eukaryotic mRNA decay. Biochim Biophys Acta 1819:593–603

    Article  CAS  PubMed  Google Scholar 

  • Bergman N, Moraes KC, Anderson JR, Zaric B, Kambach C, Schneider RJ, Wilusz CJ, Wilusz J (2007) Lsm proteins bind and stabilize RNAs containing 5′ poly(a) tracts. Nat Struct Mol Biol 14:824–831

    Article  CAS  PubMed  Google Scholar 

  • Bernstein P, Peltz SW, Ross J (1989) The poly(A)-poly(A)-binding protein complex is a major determinant of mRNA stability in vitro. Mol Cell Biol 9:659–670

    CAS  PubMed Central  PubMed  Google Scholar 

  • Boczkowski D, Nair SK, Snyder D, Gilboa E (1996) Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J Exp Med 184:465–472

    Article  CAS  PubMed  Google Scholar 

  • Boegel S, Lower M, Schafer M, Bukur T, de Graaf J, Boisguerin V, Tureci O, Tureci O, Diken M, Castle JC, Sahin U (2013) HLA typing from RNA-Seq sequence reads. Genome Med 4:102

    Article  PubMed  Google Scholar 

  • Britten CM, Singh-Jasuja H, Flamion B, Hoos A, Huber C, Kallen KJ, Khleif SN, Kreiter S, Nielsen M, Rammensee HG, Sahin U, Hinz T, Kalinke U (2013) The regulatory landscape for actively personalized cancer immunotherapies. Nat Biotechnol 31:880–882

    Article  CAS  PubMed  Google Scholar 

  • Carbone DP, Ciernik IF, Kelley MJ, Smith MC, Nadaf S, Kavanaugh D, Maher VE, Stipanov M, Contois D, Johnson BE, Pendleton CD, Seifert B, Carter C, Read EJ, Greenblatt J, Top LE, Kelsey MI, Minna JD, Berzofsky JA (2005) Immunization with mutant p53- and K-ras-derived peptides in cancer patients: immune response and clinical outcome. J Clin Oncol 23:5099–5107

    Article  PubMed  Google Scholar 

  • Carralot JP, Probst J, Hoerr I, Scheel B, Teufel R, Jung G, Rammensee HG, Pascolo S (2004) Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccines. Cell Mol Life Sci 61:2418–2424

    Article  CAS  PubMed  Google Scholar 

  • Castle JC, Kreiter S, Diekmann J, Lower M, van de Roemer N, de Graaf J, Selmi A, Diken M, Boegel S, Paret C, Koslowski M, Kuhn AN, Britten CM, Huber C, Tureci O, Sahin U (2012) Exploiting the mutanome for tumor vaccination. Cancer Res 72:1081–1091

    Article  CAS  PubMed  Google Scholar 

  • Chang JH, Xiang S, Xiang K, Manley JL, Tong L (2011) Structural and biochemical studies of the 5′→3′ exoribonuclease Xrn1. Nat Struct Mol Biol 18:270–276

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Chiu WW, Kinney RM, Dreher TW (2005) Control of translation by the 5′- and 3′-terminal regions of the dengue virus genome. J Virol 79:8303–8315

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Cibulskis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, Sougnez C, Gabriel S, Meyerson M, Lander ES, Getz G (2013) Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol 31:213–219

    Article  CAS  PubMed  Google Scholar 

  • Conry RM, LoBuglio AF, Wright M, Sumerel L, Pike MJ, Johanning F, Benjamin R, Lu D, Curiel DT (1995) Characterization of a messenger RNA polynucleotide vaccine vector. Cancer Res 55:1397–1400

    CAS  PubMed  Google Scholar 

  • Diken M, Kreiter S, Selmi A, Britten CM, Huber C, Tureci O, Sahin U (2011) Selective uptake of naked vaccine RNA by dendritic cells is driven by macropinocytosis and abrogated upon DC maturation. Gene Ther 18:702–708

    Article  CAS  PubMed  Google Scholar 

  • Diken M, Kreiter S, Selmi A, Tureci O, Sahin U (2013) Antitumor vaccination with synthetic mRNA: strategies for in vitro and in vivo preclinical studies. Methods Mol Biol 969:235–246

    Article  CAS  PubMed  Google Scholar 

  • Ding L, Ellis MJ, Li S, Larson DE, Chen K, Wallis JW, Harris CC, McLellan MD, Fulton RS, Fulton LL, Abbott RM, Hoog J, Dooling DJ, Koboldt DC, Schmidt H, Kalicki J, Zhang Q, Chen L, Lin L, Wendl MC, McMichael JF, Magrini VJ, Cook L, McGrath SD, Vickery TL, Appelbaum E, Deschryver K, Davies S, Guintoli T, Lin L, Crowder R, Tao Y, Snider JE, Smith SM, Dukes AF, Sanderson GE, Pohl CS, Delehaunty KD, Fronick CC, Pape KA, Reed JS, Robinson JS, Hodges JS, Schierding W, Dees ND, Shen D, Locke DP, Wiechert ME, Eldred JM, Peck JB, Oberkfell BJ, Lolofie JT, Du F, Hawkins AE, O’Laughlin MD, Bernard KE, Cunningham M, Elliott G, Mason MD, Thompson DM Jr, Ivanovich JL, Goodfellow PJ, Perou CM, Weinstock GM, Aft R, Watson M, Ley TJ, Wilson RK, Mardis ER (2010) Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 464:999–1005

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Duan J, Antezana MA (2003) Mammalian mutation pressure, synonymous codon choice, and mRNA degradation. J Mol Evol 57:694–701

    Article  CAS  PubMed  Google Scholar 

  • Fotin-Mleczek M, Duchardt KM, Lorenz C, Pfeiffer R, Ojkic-Zrna S, Probst J, Kallen KJ (2011) Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity. J Immunother 34:1–15

    Article  CAS  PubMed  Google Scholar 

  • Garneau NL, Wilusz J, Wilusz CJ (2007) The highways and byways of mRNA decay. Nat Rev Mol Cell Biol 8:113–126

    Article  CAS  PubMed  Google Scholar 

  • Garneau NL, Sokoloski KJ, Opyrchal M, Neff CP, Wilusz CJ, Wilusz J (2008) The 3′ untranslated region of sindbis virus represses deadenylation of viral transcripts in mosquito and mammalian cells. J Virol 82:880–892

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Grantham R, Gautier C, Gouy M, Mercier R, Pave A (1980) Codon catalog usage and the genome hypothesis. Nucleic Acids Res 8:r49–r62

    CAS  PubMed Central  PubMed  Google Scholar 

  • Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C, Edkins S, O’Meara S, Vastrik I, Schmidt EE, Avis T, Barthorpe S, Bhamra G, Buck G, Choudhury B, Clements J, Cole J, Dicks E, Forbes S, Gray K, Halliday K, Harrison R, Hills K, Hinton J, Jenkinson A, Jones D, Menzies A, Mironenko T, Perry J, Raine K, Richardson D, Shepherd R, Small A, Tofts C, Varian J, Webb T, West S, Widaa S, Yates A, Cahill DP, Louis DN, Goldstraw P, Nicholson AG, Brasseur F, Looijenga L, Weber BL, Chiew YE, DeFazio A, Greaves MF, Green AR, Campbell P, Birney E, Easton DF, Chenevix-Trench G, Tan MH, Khoo SK, Teh BT, Yuen ST, Leung SY, Wooster R, Futreal PA, Stratton MR (2007) Patterns of somatic mutation in human cancer genomes. Nature 446:153–158

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Grudzien-Nogalska E, Jemielity J, Kowalska J, Darzynkiewicz E, Rhoads RE (2007) Phosphorothioate cap analogs stabilize mRNA and increase translational efficiency in mammalian cells. RNA 13:1745–1755

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Grudzien-Nogalska E, Kowalska J, Su W, Kuhn AN, Slepenkov SV, Darzynkiewicz E, Sahin U, Jemielity J, Rhoads RE (2013) Synthetic mRNAs with superior translation and stability properties. Methods Mol Biol 969:55–72

    Article  CAS  PubMed  Google Scholar 

  • Hoerr I, Obst R, Rammensee HG, Jung G (2000) In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies. Eur J Immunol 30:1–7

    Article  CAS  PubMed  Google Scholar 

  • Holtkamp S, Kreiter S, Selmi A, Simon P, Koslowski M, Huber C, Tureci O, Sahin U (2006) Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells. Blood 108:4009–4017

    Article  CAS  PubMed  Google Scholar 

  • Houseley J, Tollervey D (2009) The many pathways of RNA degradation. Cell 136:763–776

    Article  CAS  PubMed  Google Scholar 

  • Inaba K, Metlay JP, Crowley MT, Steinman RM (1990) Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J Exp Med 172:631–640

    Article  CAS  PubMed  Google Scholar 

  • Jacobson A, Peltz SW (1996) Interrelationships of the pathways of mRNA decay and translation in eukaryotic cells. Annu Rev Biochem 65:693–739

    Article  CAS  PubMed  Google Scholar 

  • Jemielity J, Fowler T, Zuberek J, Stepinski J, Lewdorowicz M, Niedzwiecka A, Stolarski R, Darzynkiewicz E, Rhoads RE (2003) Novel “anti-reverse” cap analogs with superior translational properties. RNA 9:1108–1122

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Jinek M, Coyle SM, Doudna JA (2011) Coupled 5′ nucleotide recognition and processivity in Xrn1-mediated mRNA decay. Mol Cell 41:600–608

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Kamiyama H, Jimeno A, Hong SM, Fu B, Lin MT, Calhoun ES, Kamiyama M, Walter K, Nikolskaya T, Nikolsky Y, Hartigan J, Smith DR, Hidalgo M, Leach SD, Klein AP, Jaffee EM, Goggins M, Maitra A, Iacobuzio-Donahue C, Eshleman JR, Kern SE, Hruban RH, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321:1801–1806

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Khabar KS (2005) The AU-rich transcriptome: more than interferons and cytokines, and its role in disease. J Interferon Cytokine Res 25:1–10

    Article  CAS  PubMed  Google Scholar 

  • Koboldt DC, Steinberg KM, Larson DE, Wilson RK, Mardis ER (2013) The next-generation sequencing revolution and its impact on genomics. Cell 155:27–38

    Article  CAS  PubMed  Google Scholar 

  • Kowalska J, Lewdorowicz M, Zuberek J, Grudzien-Nogalska E, Bojarska E, Stepinski J, Rhoads RE, Darzynkiewicz E, Davis RE, Jemielity J (2008) Synthesis and characterization of mRNA cap analogs containing phosphorothioate substitutions that bind tightly to eIF4E and are resistant to the decapping pyrophosphatase DcpS. RNA 14:1119–1131

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Kreiter S, Konrad T, Sester M, Huber C, Tureci O, Sahin U (2007) Simultaneous ex vivo quantification of antigen-specific CD4+ and CD8+ T cell responses using in vitro transcribed RNA. Cancer Immunol Immunother 56:1577–1587

    Article  CAS  PubMed  Google Scholar 

  • Kreiter S, Selmi A, Diken M, Sebastian M, Osterloh P, Schild H, Huber C, Tureci O, Sahin U (2008) Increased antigen presentation efficiency by coupling antigens to MHC class I trafficking signals. J Immunol 180:309–318

    Article  CAS  PubMed  Google Scholar 

  • Kreiter S, Selmi A, Diken M, Koslowski M, Britten CM, Huber C, Tureci O, Sahin U (2010) Intranodal vaccination with naked antigen-encoding RNA elicits potent prophylactic and therapeutic antitumoral immunity. Cancer Res 70:9031–9040

    Article  CAS  PubMed  Google Scholar 

  • Kreiter S, Diken M, Selmi A, Diekmann J, Attig S, Husemann Y, Koslowski M, Huber C, Tureci O, Sahin U (2011a) FLT3 Ligand enhances the cancer therapeutic potency of naked RNA vaccines. Cancer Res 71:6132–6142

    Article  CAS  PubMed  Google Scholar 

  • Kreiter S, Diken M, Selmi A, Tureci O, Sahin U (2011b) Tumor vaccination using messenger RNA: prospects of a future therapy. Curr Opin Immunol 23:399–406

    Article  CAS  PubMed  Google Scholar 

  • Kuhn AN, Diken M, Kreiter S, Selmi A, Kowalska J, Jemielity J, Darzynkiewicz E, Huber C, Tureci O, Sahin U (2010) Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo. Gene Ther 17:961–971

    Article  CAS  PubMed  Google Scholar 

  • Kuhn AN, Diken M, Kreiter S, Vallazza B, Tureci O, Sahin U (2011) Determinants of intracellular RNA pharmacokinetics: implications for RNA-based immunotherapeutics. RNA Biol 8:35–43

    Article  CAS  PubMed  Google Scholar 

  • Kuhn AN, Beibetaert T, Simon P, Vallazza B, Buck J, Davies BP, Tureci O, Sahin U (2012) MRNA as a versatile tool for exogenous protein expression. Curr Gene Ther 12:347–361

    Article  CAS  PubMed  Google Scholar 

  • Lee W, Jiang Z, Liu J, Haverty PM, Guan Y, Stinson J, Yue P, Zhang Y, Pant KP, Bhatt D, Ha C, Johnson S, Kennemer MI, Mohan S, Nazarenko I, Watanabe C, Sparks AB, Shames DS, Gentleman R, de Sauvage FJ, Stern H, Pandita A, Ballinger DG, Drmanac R, Modrusan Z, Seshagiri S, Zhang Z (2010) The mutation spectrum revealed by paired genome sequences from a lung cancer patient. Nature 465:473–477

    Article  CAS  PubMed  Google Scholar 

  • Lower M, Renard BY, de Graaf J, Wagner M, Paret C, Kneip C, Tureci O, Diken M, Britten C, Kreiter S, Koslowski M, Castle JC, Sahin U (2012) Confidence-based somatic mutation evaluation and prioritization. PLoS Comput Biol 8:e1002714

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Lundegaard C, Lamberth K, Harndahl M, Buus S, Lund O, Nielsen M (2008) NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8–11. Nucleic Acids Res 36:W509–W512

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Lykke-Andersen S, Tomecki R, Jensen TH, Dziembowski A (2011) The eukaryotic RNA exosome: same scaffold but variable catalytic subunits. RNA Biol 8:61–66

    Article  CAS  PubMed  Google Scholar 

  • Martinon F, Krishnan S, Lenzen G, Magne R, Gomard E, Guillet JG, Levy JP, Meulien P (1993) Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA. Eur J Immunol 23:1719–1722

    Article  CAS  PubMed  Google Scholar 

  • Matsushita H, Vesely MD, Koboldt DC, Rickert CG, Uppaluri R, Magrini VJ, Arthur CD, White JM, Chen YS, Shea LK, Hundal J, Wendl MC, Demeter R, Wylie T, Allison JP, Smyth MJ, Old LJ, Mardis ER, Schreiber RD (2012) Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting. Nature 482:400–404

    Article  CAS  PubMed  Google Scholar 

  • Meyer S, Temme C, Wahle E (2004) Messenger RNA turnover in eukaryotes: pathways and enzymes. Crit Rev Biochem Mol Biol 39:197–216

    Article  CAS  PubMed  Google Scholar 

  • Mockey M, Bourseau E, Chandrashekhar V, Chaudhuri A, Lafosse S, Le CE, Quesniaux VF, Ryffel B, Pichon C, Midoux P (2007) mRNA-based cancer vaccine: prevention of B16 melanoma progression and metastasis by systemic injection of MART1 mRNA histidylated lipopolyplexes. Cancer Gene Ther 14:802–814

    Article  CAS  PubMed  Google Scholar 

  • Morse MA, Lyerly HK, Gilboa E, Thomas E, Nair SK (1998) Optimization of the sequence of antigen loading and CD40-ligand-induced maturation of dendritic cells. Cancer Res 58:2965–2968

    CAS  PubMed  Google Scholar 

  • Moura GR, Pinheiro M, Freitas A, Oliveira JL, Frommlet JC, Carreto L, Soares AR, Bezerra AR, Santos MA (2011) Species-specific codon context rules unveil non-neutrality effects of synonymous mutations. PLoS One 6:e26817

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, Olivi A, McLendon R, Rasheed BA, Keir S, Nikolskaya T, Nikolsky Y, Busam DA, Tekleab H, Diaz LA Jr, Hartigan J, Smith DR, Strausberg RL, Marie SK, Shinjo SM, Yan H, Riggins GJ, Bigner DD, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807–1812

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Pascolo S (2008) Vaccination with messenger RNA (mRNA). Handb Exp Pharmacol (183):221–235

    Article  Google Scholar 

  • Pasquinelli AE, Dahlberg JE, Lund E (1995) Reverse 5′ caps in RNAs made in vitro by phage RNA polymerases. RNA 1:957–967

    CAS  PubMed Central  PubMed  Google Scholar 

  • Peng ZH, Sharma V, Singleton SF, Gershon PD (2002) Synthesis and application of a chain-terminating dinucleotide mRNA cap analog. Org Lett 4:161–164

    Article  CAS  PubMed  Google Scholar 

  • Perche F, Benvegnu T, Berchel M, Lebegue L, Pichon C, Jaffres PA, Midoux P (2011) Enhancement of dendritic cells transfection in vivo and of vaccination against B16F10 melanoma with mannosylated histidylated lipopolyplexes loaded with tumor antigen messenger RNA. Nanomedicine 7:445–453

    Article  CAS  PubMed  Google Scholar 

  • Pleasance ED, Cheetham RK, Stephens PJ, McBride DJ, Humphray SJ, Greenman CD, Varela I, Lin ML, Ordonez GR, Bignell GR, Ye K, Alipaz J, Bauer MJ, Beare D, Butler A, Carter RJ, Chen L, Cox AJ, Edkins S, Kokko-Gonzales PI, Gormley NA, Grocock RJ, Haudenschild CD, Hims MM, James T, Jia M, Kingsbury Z, Leroy C, Marshall J, Menzies A, Mudie LJ, Ning Z, Royce T, Schulz-Trieglaff OB, Spiridou A, Stebbings LA, Szajkowski L, Teague J, Williamson D, Chin L, Ross MT, Campbell PJ, Bentley DR, Futreal PA, Stratton MR (2010a) A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463:191–196

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Pleasance ED, Stephens PJ, O’Meara S, McBride DJ, Meynert A, Jones D, Lin ML, Beare D, Lau KW, Greenman C, Varela I, Nik-Zainal S, Davies HR, Ordonez GR, Mudie LJ, Latimer C, Edkins S, Stebbings L, Chen L, Jia M, Leroy C, Marshall J, Menzies A, Butler A, Teague JW, Mangion J, Sun YA, McLaughlin SF, Peckham HE, Tsung EF, Costa GL, Lee CC, Minna JD, Gazdar A, Birney E, Rhodes MD, McKernan KJ, Stratton MR, Futreal PA, Campbell PJ (2010b) A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 463:184–190

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Pogue GP, Cao XQ, Singh NK, Nakhasi HL (1993) 5′ sequences of rubella virus RNA stimulate translation of chimeric RNAs and specifically interact with two host-encoded proteins. J Virol 67:7106–7117

    CAS  PubMed Central  PubMed  Google Scholar 

  • Ponsaerts P, Van den Bosch G, Cools N, Van DA, Nijs G, Lenjou M, Lardon F, Van BC, Van Bockstaele DR, Berneman ZN, Van Tendeloo VF (2002) Messenger RNA electroporation of human monocytes, followed by rapid in vitro differentiation, leads to highly stimulatory antigen-loaded mature dendritic cells. J Immunol 169:1669–1675

    Article  CAS  PubMed  Google Scholar 

  • Qiu P, Ziegelhoffer P, Sun J, Yang NS (1996) Gene gun delivery of mRNA in situ results in efficient transgene expression and genetic immunization. Gene Ther 3:262–268

    CAS  PubMed  Google Scholar 

  • Rahma OE, Ashtar E, Ibrahim R, Toubaji A, Gause B, Herrin VE, Linehan WM, Steinberg SM, Grollman F, Grimes G, Bernstein SA, Berzofsky JA, Khleif SN (2010) A pilot clinical trial testing mutant von Hippel-Lindau peptide as a novel immune therapy in metastatic renal cell carcinoma. J Transl Med 8:8

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Rains N, Cannan RJ, Chen W, Stubbs RS (2001) Development of a dendritic cell (DC)-based vaccine for patients with advanced colorectal cancer. Hepatogastroenterology 48:347–351

    CAS  PubMed  Google Scholar 

  • Rittig SM, Haentschel M, Weimer KJ, Heine A, Muller MR, Brugger W, Horger MS, Maksimovic O, Stenzl A, Hoerr I, Rammensee HG, Holderried TA, Kanz L, Pascolo S, Brossart P (2011) Intradermal vaccinations with RNA coding for TAA generate CD8+ and CD4+ immune responses and induce clinical benefit in vaccinated patients. Mol Ther 19:990–999

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Robbins PF, Lu YC, el-Gamil M, Li YF, Gross C, Gartner J, Lin JC, Teer JK, Cliften P, Tycksen E, Samuels Y, Rosenberg SA (2013) Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells. Nat Med 19:747–752

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Rock KL, Gamble S, Rothstein L (1990) Presentation of exogenous antigen with class I major histocompatibility complex molecules. Science 249:918–921

    Article  CAS  PubMed  Google Scholar 

  • Rydzik AM, Kulis M, Lukaszewicz M, Kowalska J, Zuberek J, Darzynkiewicz ZM, Darzynkiewicz E, Jemielity J (2012) Synthesis and properties of mRNA cap analogs containing imidodiphosphate moiety–fairly mimicking natural cap structure, yet resistant to enzymatic hydrolysis. Bioorg Med Chem 20:1699–1710

    Article  CAS  PubMed  Google Scholar 

  • Sachs AB, Davis RW, Kornberg RD (1987) A single domain of yeast poly(A)-binding protein is necessary and sufficient for RNA binding and cell viability. Mol Cell Biol 7:3268–3276

    CAS  PubMed Central  PubMed  Google Scholar 

  • Sahin U, Tureci O, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I, Pfreundschuh M (1995) Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci U S A 92:11810–11813

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Scheel B, Teufel R, Probst J, Carralot JP, Geginat J, Radsak M, Jarrossay D, Wagner H, Jung G, Rammensee HG, Hoerr I, Pascolo S (2005) Toll-like receptor-dependent activation of several human blood cell types by protamine-condensed mRNA. Eur J Immunol 35:1557–1566

    Article  CAS  PubMed  Google Scholar 

  • Scholtalbers J, Rossler J, Sorn P, de Graaf J, Boisguerin V, Castle J, Sahin U (2013) Galaxy LIMS for next-generation sequencing. Bioinformatics 29:1233–1234

    Article  CAS  PubMed  Google Scholar 

  • Sjoberg EM, Suomalainen M, Garoff H (1994) A significantly improved Semliki Forest virus expression system based on translation enhancer segments from the viral capsid gene. Biotechnology (N Y) 12:1127–1131

    Article  CAS  Google Scholar 

  • Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JK, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314:268–274

    Article  PubMed  CAS  Google Scholar 

  • Song MG, Li Y, Kiledjian M (2010) Multiple mRNA decapping enzymes in mammalian cells. Mol Cell 40:423–432

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Steitz J, Britten CM, Wolfel T, Tuting T (2006) Effective induction of anti-melanoma immunity following genetic vaccination with synthetic mRNA coding for the fusion protein EGFP.TRP2. Cancer Immunol Immunother 55:246–253

    Article  CAS  PubMed  Google Scholar 

  • Stepinski J, Waddell C, Stolarski R, Darzynkiewicz E, Rhoads RE (2001) Synthesis and properties of mRNAs containing the novel “anti-reverse” cap analogs 7-methyl(3′–O-methyl)GpppG and 7-methyl (3′-deoxy)GpppG. RNA 7:1486–1495

    CAS  PubMed Central  PubMed  Google Scholar 

  • Stratton MR (2011) Exploring the genomes of cancer cells: progress and promise. Science 331:1553–1558

    Article  CAS  PubMed  Google Scholar 

  • Totoki Y, Tatsuno K, Yamamoto S, Arai Y, Hosoda F, Ishikawa S, Tsutsumi S, Sonoda K, Totsuka H, Shirakihara T, Sakamoto H, Wang L, Ojima H, Shimada K, Kosuge T, Okusaka T, Kato K, Kusuda J, Yoshida T, Aburatani H, Shibata T (2011) High-resolution characterization of a hepatocellular carcinoma genome. Nat Genet 43:464–469

    Article  CAS  PubMed  Google Scholar 

  • van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B, Knuth A, Boon T (1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254:1643–1647

    Article  PubMed  Google Scholar 

  • van der Werf S, Bradley J, Wimmer E, Studier FW, Dunn JJ (1986) Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase. Proc Natl Acad Sci U S A 83:2330–2334

    Article  PubMed Central  PubMed  Google Scholar 

  • Van Lint S, Goyvaerts C, Maenhout S, Goethals L, Disy A, Benteyn D, Pen J, Bonehill A, Heirman C, Breckpot K, Thielemans K (2012) Preclinical evaluation of TriMix and antigen mRNA-based antitumor therapy. Cancer Res 72:1661–1671

    Article  PubMed  CAS  Google Scholar 

  • Van Lint S, Heirman C, Thielemans K, Breckpot K (2013) mRNA: from a chemical blueprint for protein production to an off-the-shelf therapeutic. Hum Vaccin Immunother 9:265–274

    Google Scholar 

  • van Rooij N, van Buuren MM, Philips D, Velds A, Toebes M, Heemskerk B, van Dijk LJ, Behjati S, Hilkmann H, El Atmioui D, Nieuwland M, Stratton MR, Kerkhoven RM, Kesmir C, Haanen JB, Kvistborg P, Schumacher TN (2013) Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma. J Clin Oncol 31:e439–e442

    Article  PubMed  Google Scholar 

  • Van Tendeloo VF, Ponsaerts P, Lardon F, Nijs G, Lenjou M, Van BC, Van Bockstaele DR, Berneman ZN (2001) Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells. Blood 98:49–56

    Article  PubMed  Google Scholar 

  • Waggoner SA, Liebhaber SA (2003) Identification of mRNAs associated with alphaCP2-containing RNP complexes. Mol Cell Biol 23:7055–7067

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Warminski M, Kowalska J, Buck J, Zuberek J, Lukaszewicz M, Nicola C, Kuhn AN, Sahin U, Darzynkiewicz E, Jemielity J (2013) The synthesis of isopropylidene mRNA cap analogs modified with phosphorothioate moiety and their evaluation as promoters of mRNA translation. Bioorg Med Chem Lett 23:3753–3758

    Article  CAS  PubMed  Google Scholar 

  • Wei X, Walia V, Lin JC, Teer JK, Prickett TD, Gartner J, Davis S, Stemke-Hale K, Davies MA, Gershenwald JE, Robinson W, Robinson S, Rosenberg SA, Samuels Y (2011) Exome sequencing identifies GRIN2A as frequently mutated in melanoma. Nat Genet 43:442–446

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Weide B, Carralot JP, Reese A, Scheel B, Eigentler TK, Hoerr I, Rammensee HG, Garbe C, Pascolo S (2008) Results of the first phase I/II clinical vaccination trial with direct injection of mRNA. J Immunother 31:180–188

    Article  CAS  PubMed  Google Scholar 

  • Wolfel C, Lennerz V, Lindemann E, Hess G, Derigs HG, Huber C, Herr W, Wolfel T (2008) Dissection and molecular analysis of alloreactive CD8+ T cell responses in allogeneic haematopoietic stem cell transplantation. Cancer Immunol Immunother 57:849–857

    Article  PubMed  CAS  Google Scholar 

  • Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Felgner PL (1990) Direct gene transfer into mouse muscle in vivo. Science 247:1465–1468

    Article  CAS  PubMed  Google Scholar 

  • Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, Leary RJ, Shen D, Boca SM, Barber T, Ptak J, Silliman N, Szabo S, Dezso Z, Ustyanksky V, Nikolskaya T, Nikolsky Y, Karchin R, Wilson PA, Kaminker JS, Zhang Z, Croshaw R, Willis J, Dawson D, Shipitsin M, Willson JK, Sukumar S, Polyak K, Park BH, Pethiyagoda CL, Pant PV, Ballinger DG, Sparks AB, Hartigan J, Smith DR, Suh E, Papadopoulos N, Buckhaults P, Markowitz SD, Parmigiani G, Kinzler KW, Velculescu VE, Vogelstein B (2007) The genomic landscapes of human breast and colorectal cancers. Science 318:1108–1113

    Article  CAS  PubMed  Google Scholar 

  • Ying H, Zaks TZ, Wang RF, Irvine KR, Kammula US, Marincola FM, Leitner WW, Restifo NP (1999) Cancer therapy using a self-replicating RNA vaccine. Nat Med 5:823–827

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Yu J, Russell JE (2001) Structural and functional analysis of an mRNP complex that mediates the high stability of human beta-globin mRNA. Mol Cell Biol 21:5879–5888

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Zhou X, Berglund P, Rhodes G, Parker SE, Jondal M, Liljestrom P (1994) Self-replicating Semliki Forest virus RNA as recombinant vaccine. Vaccine 12:1510–1514

    Article  CAS  PubMed  Google Scholar 

  • Zhou WZ, Hoon DS, Huang SK, Fujii S, Hashimoto K, Morishita R, Kaneda Y (1999) RNA melanoma vaccine: induction of antitumor immunity by human glycoprotein 100 mRNA immunization. Hum Gene Ther 10:2719–2724

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. TRON-Translational Oncology University Medical Center, Johannes Gutenberg University, Mainz, 55131, Germany

    S. Kreiter & U. Sahin

  2. BioNTech AG, Mainz, 55131, Germany

    S. Kreiter & U. Sahin

  3. Department of Immunotherapy Development Center, TRON-Translational Oncology University Medical Center, Johannes Gutenberg University, Mainz, 55131, Germany

    M. Diken

Authors
  1. S. Kreiter
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Diken
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. U. Sahin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to U. Sahin .

Editor information

Editors and Affiliations

  1. Immunotherapy Development Center (IDC), TRON-Translational Oncology University Medical Center, Johannes Gutenberg University, Mainz, Germany

    Cedrik Michael Britten

  2. Department of Immunotherapy Development Center, TRON-Translational Oncology University Medical Center, Johannes Gutenberg-University, Mainz, Germany

    Sebastian Kreiter

  3. Department of Immunotherapy Development Center, TRON-Translational Oncology University Medical Center, Johannes Gutenberg University, Mainz, Germany

    Mustafa Diken

  4. Department of Immunology, University of Tübingen, Tübingen, Germany

    Hans-Georg Rammensee

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Kreiter, S., Diken, M., Sahin, U. (2014). mRNA Vaccination and Personalized Cancer Therapy. In: Britten, C., Kreiter, S., Diken, M., Rammensee, HG. (eds) Cancer Immunotherapy Meets Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-05104-8_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-05104-8_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-05103-1

  • Online ISBN: 978-3-319-05104-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation